Format

Send to

Choose Destination
See comment in PubMed Commons below
Obstet Gynecol Clin North Am. 2003 Sep;30(3):545-58, vii.

Substance use disorders in women: special considerations during pregnancy.

Author information

1
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, School of Medicine, 2211 Lomas Boulevard NE, MSC 10-5580, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA. jbolnick@salud.unm.edu

Abstract

Care of substance-using pregnant women is complex, difficult, and often demanding. Women's care providers must be aware of these women's unique psychologic and social needs and the related legal and ethical ramifications surrounding pregnancy. In addition, relating specific substances to perinatal outcome is difficult, because concurrent use of multiple substances is frequent and many pregnant abusers are members of economically disadvantaged segments of society in which unfavorable perinatal outcomes are more common. It is also difficult to follow up outcomes in such pregnancies prospectively and to analyze research data. This article discusses various issues related to pregnancies complicated by substance use, including perinatal pharmacology and teratogenic risks, identification of substance abuse, treatment approaches, and comprehensive perinatal management.

PMID:
14664326
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center